1450 related articles for article (PubMed ID: 28577568)
1. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
2. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371
[TBL] [Abstract][Full Text] [Related]
3. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.
Liu Y; Lu F; Kang L; Wang Z; Wang Y
BMC Pulm Med; 2017 Apr; 17(1):63. PubMed ID: 28420366
[TBL] [Abstract][Full Text] [Related]
6. PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis.
Araya J; Tsubouchi K; Sato N; Ito S; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Yoshida M; Fujita Y; Utsumi H; Kobayashi K; Yanagisawa H; Hashimoto M; Wakui H; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nishimura SL; Nakayama K; Kuwano K
Autophagy; 2019 Mar; 15(3):510-526. PubMed ID: 30290714
[TBL] [Abstract][Full Text] [Related]
7. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3).
Wu C; Lin H; Zhang X
Int Immunopharmacol; 2019 Sep; 74():105700. PubMed ID: 31228816
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1.
Sosulski ML; Gongora R; Danchuk S; Dong C; Luo F; Sanchez CG
Aging Cell; 2015 Oct; 14(5):774-83. PubMed ID: 26059457
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
[TBL] [Abstract][Full Text] [Related]
12. Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.
Huang LS; Jiang P; Feghali-Bostwick C; Reddy SP; Garcia JGN; Natarajan V
Free Radic Biol Med; 2017 Nov; 112():162-173. PubMed ID: 28751023
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation.
Dong J; Ma Q
Part Fibre Toxicol; 2017 Jun; 14(1):18. PubMed ID: 28595626
[TBL] [Abstract][Full Text] [Related]
14. PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.
Tsubouchi K; Araya J; Kuwano K
Inflamm Regen; 2018; 38():18. PubMed ID: 30386443
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis.
Larson-Casey JL; Deshane JS; Ryan AJ; Thannickal VJ; Carter AB
Immunity; 2016 Mar; 44(3):582-596. PubMed ID: 26921108
[TBL] [Abstract][Full Text] [Related]
16. Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.
Fang L; Chen H; Kong R; Que J
Life Sci; 2020 Nov; 260():118399. PubMed ID: 32918977
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
19. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
20. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
